Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias
Aim. To study efficacy of maintenance therapy of patients with acute promyelocyte leukemia (APL) in the APL treatment Russian multicenter trial. Material and methods. The trial was made with participation of 18 hematological departments of clinics in Russia. A total of 68 APL patients entered the tr...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2004-07-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/29988 |
id |
doaj-129b1e827ef44a0e9cb3fd66f1b94537 |
---|---|
record_format |
Article |
spelling |
doaj-129b1e827ef44a0e9cb3fd66f1b945372020-11-25T03:00:07Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422004-07-01797111827016Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemiasE N ParovichnikovaV G SavchenkoI A DemidovaV G IsaevE N ShuravinaE N UstinovaE O GribanovaM Zh AlexanyanA V MisyurinE V DomrachevaYu V OlshanskayaN D KhoroshkoS K KravchenkoT S KonstantinovaL V AnchukovaK KaplanovT P ZagoskinaS A VolkovaL В FilatovG В RekhtmanI SokolovaV N MashukG I MilyulinaV A LapinT N PerekatovaE I SviridovaA S PristupaI S ZyuzginAim. To study efficacy of maintenance therapy of patients with acute promyelocyte leukemia (APL) in the APL treatment Russian multicenter trial. Material and methods. The trial was made with participation of 18 hematological departments of clinics in Russia. A total of 68 APL patients entered the trial. The maintenance therapy consisted of 5day courses of cytostatic drugs which alternated or did not altenate with 5-day courses of ATRA. Cytogenetic tests were made in 31 patients, t(15;17) was detected in 26 of them. Molecular examination conducted in 28 patients discovered chimeric transcript PML/RARa in 26 of them. Of 20 patients examined in Hematological Research Center, 7 (35%) had a bcr 1/2 variant of the transcript PML/RARa, 13 (657c) - bcr 3 variant. Results. 65 patients were eligible for assessment. A complete remission was achieved in 90% cases. No resistance was observed. In follow-up within 30 months the recurrence rate was similar on both treatments. The results of the induction therapy and survival in patients with different variants of the transcripts were also simitar. Overall 2.5 year survival for all the patients was 77%, recurrence-free 80%. The survival analysis in patients with leukocytosis higher and lower 10 lO9/! found no statistical differences by the survival. Patients with hyperleukocytosis had higher early lethality than patients with leukocytes under 10 Iff/I (25% vs 5.3%, p = 0.03). Conclusion. The APL 06.01 protocol showed high efficacy of the relevant maintenance which provides a complete molecular remission in the majority of patients with probable recurrence-free 2.5 year survival 80%.https://ter-arkhiv.ru/0040-3660/article/view/29988fishacutepromyelocytic leukemiapolymerase chain reactionfishrandomisation |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
E N Parovichnikova V G Savchenko I A Demidova V G Isaev E N Shuravina E N Ustinova E O Gribanova M Zh Alexanyan A V Misyurin E V Domracheva Yu V Olshanskaya N D Khoroshko S K Kravchenko T S Konstantinova L V Anchukova K Kaplanov T P Zagoskina S A Volkova L В Filatov G В Rekhtman I Sokolova V N Mashuk G I Milyulina V A Lapin T N Perekatova E I Sviridova A S Pristupa I S Zyuzgin |
spellingShingle |
E N Parovichnikova V G Savchenko I A Demidova V G Isaev E N Shuravina E N Ustinova E O Gribanova M Zh Alexanyan A V Misyurin E V Domracheva Yu V Olshanskaya N D Khoroshko S K Kravchenko T S Konstantinova L V Anchukova K Kaplanov T P Zagoskina S A Volkova L В Filatov G В Rekhtman I Sokolova V N Mashuk G I Milyulina V A Lapin T N Perekatova E I Sviridova A S Pristupa I S Zyuzgin Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias Терапевтический архив fish acutepromyelocytic leukemia polymerase chain reaction fish randomisation |
author_facet |
E N Parovichnikova V G Savchenko I A Demidova V G Isaev E N Shuravina E N Ustinova E O Gribanova M Zh Alexanyan A V Misyurin E V Domracheva Yu V Olshanskaya N D Khoroshko S K Kravchenko T S Konstantinova L V Anchukova K Kaplanov T P Zagoskina S A Volkova L В Filatov G В Rekhtman I Sokolova V N Mashuk G I Milyulina V A Lapin T N Perekatova E I Sviridova A S Pristupa I S Zyuzgin |
author_sort |
E N Parovichnikova |
title |
Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias |
title_short |
Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias |
title_full |
Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias |
title_fullStr |
Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias |
title_full_unstemmed |
Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias |
title_sort |
preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias |
publisher |
"Consilium Medicum" Publishing house |
series |
Терапевтический архив |
issn |
0040-3660 2309-5342 |
publishDate |
2004-07-01 |
description |
Aim. To study efficacy of maintenance therapy of patients with acute promyelocyte leukemia (APL) in the APL treatment Russian multicenter trial.
Material and methods. The trial was made with participation of 18 hematological departments of clinics in Russia. A total of 68 APL patients entered the trial. The maintenance therapy consisted of 5day courses of cytostatic drugs which alternated or did not altenate with 5-day courses of ATRA. Cytogenetic tests were made in 31 patients, t(15;17) was detected in 26 of them. Molecular examination conducted in 28 patients discovered chimeric transcript PML/RARa in 26 of them. Of 20 patients examined in Hematological Research Center, 7 (35%) had a bcr 1/2 variant of the transcript PML/RARa, 13 (657c) - bcr 3 variant.
Results. 65 patients were eligible for assessment. A complete remission was achieved in 90% cases. No resistance was observed. In follow-up within 30 months the recurrence rate was similar on both treatments. The results of the induction therapy and survival in patients with different variants of the transcripts were also simitar. Overall 2.5 year survival for all the patients was 77%, recurrence-free 80%. The survival analysis in patients with leukocytosis higher and lower 10 lO9/! found no statistical differences by the survival. Patients with hyperleukocytosis had higher early lethality than patients with leukocytes under 10 Iff/I (25% vs 5.3%, p = 0.03).
Conclusion. The APL 06.01 protocol showed high efficacy of the relevant maintenance which provides a complete molecular remission in the majority of patients with probable recurrence-free 2.5 year survival 80%. |
topic |
fish acutepromyelocytic leukemia polymerase chain reaction fish randomisation |
url |
https://ter-arkhiv.ru/0040-3660/article/view/29988 |
work_keys_str_mv |
AT enparovichnikova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT vgsavchenko preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT iademidova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT vgisaev preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT enshuravina preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT enustinova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT eogribanova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT mzhalexanyan preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT avmisyurin preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT evdomracheva preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT yuvolshanskaya preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT ndkhoroshko preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT skkravchenko preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT tskonstantinova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT lvanchukova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT kkaplanov preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT tpzagoskina preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT savolkova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT lvfilatov preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT gvrekhtman preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT isokolova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT vnmashuk preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT gimilyulina preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT valapin preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT tnperekatova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT eisviridova preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT aspristupa preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias AT iszyuzgin preliminaryresultsofamulticenterrandomizedstudyonthetreatmentofacutepromyelocyticleukemias |
_version_ |
1724699269772869632 |